Regemat 3D Company
REGEMAT 3D is a biotech company focused on regenerative medicine and pioneer in a new and promising area called bioprinting, that uses 3D printing technologies for regenerative therapies. REGEMAT3D is a bioprinting modular system that integrates the latest advances in 3D printing and regenerative therapies to offer adapted solutions to fulfil research's needs. A tested and validated systems, it is adaptable to different types of tissues, to research the biggest unsolved biotechnology problems and to battle different kinds of pathologies, such as; Cardiovascular Disease (CVD), Peripheral Vascular Disease (PVD), Non-healing wounds, Spinal cord injury, Alzheimer´s Disease (AD), Parkinson´s Disease (PD), Musculoskeletal Disorders (MSDs), Autoimmune Disorders, Stroke, Diabetes, and Ocular Disease.
Industry:
Geroscience
Headquarters:
Armilla, Andalucia, Spain
Zip:
11-50
Founded Date:
2015-01-01
Employees Number:
11-50
Acquisitions Number:
1
Investors Number:
1095799
Total Funding:
Less than $1M
Estimated Revenue:
Less than $1M
Last Funding Date:
Equity Crowdfunding
Last Funding Type:
info@regemat3d.com
Register and Claim Ownership